Gangliosides do not affect ABC transporter function in human neuroblastoma cells

Journal of Lipid Research

Volumn 47, Issue 6, 2006, Pages 1187-1195

  Dijkhuis, Anne Jan ^a,b   Klappe, Karin ^a   Kamps, Willem ^b   Sietsma, Hannie ^a   Kok, Jan Willem ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

D,L threo 1 phenyl 2 hexadecanoylamino 3 pyrrolidino 1 propanol; Detergent resistant membrane; Glucosylceramide synthase; Multidrug resistance related protein 1; N butyldeoxynojirimycin; P glycoprotein

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ABC TRANSPORTER; CERAMIDE GLUCOSYLTRANSFERASE; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; CHOLERA TOXIN; DEXTRO,LEVO THREO 1 PHENYL 2 HEXADECANOYLAMINO 3 PYRROLIDINO 1 PROPANOL; ELACRIDAR; GANGLIOSIDE; GANGLIOSIDE GM1; GLYCOPROTEIN P; MIGLUSTAT; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG; VERLUKAST; VINCRISTINE;

ARTICLE; CELL MEMBRANE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME INHIBITION; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOLECULAR WEIGHT; MULTIDRUG RESISTANCE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

1-DEOXYNOJIRIMYCIN; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CERAMIDES; ENZYME INHIBITORS; GANGLIOSIDES; GLUCOSYLTRANSFERASES; HUMANS; IMMUNOBLOTTING; NEUROBLASTOMA; P-GLYCOPROTEIN;

EID: 33744798746     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500518-JLR200     Document Type: Article

References (40)

1. Ling, V., N. Kartner, T. Sudo, L. Siminovitch, and J. R. Riordan. 1983. Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat. Rep. 67: 869-874.
2. Biedler, J. L. 1994. Drug resistance: genotype versus phenotype. Thirty-second G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54: 666-678.
3. Nooter, K., and G. Stoter. 1996. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192: 768-780.
4. Ferte, J. 2000. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267: 277-294.
5. Lavie, Y., H. Cao, S. L. Bursten, A. E. Giuliano, and M. C. Cabot. 1996. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem. 271: 19530-19536.
6. Lucci, A., W. I. Cho, T. Y. Han, A. E. Giuliano, D. L. Morton, and M. C. Cabot. 1998. Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res. 18: 475-480.
7. Kok, J. W., R. J. Veldman, K. Klappe, H. Koning, C. M. Filipeanu, and M. Muller. 2000. Differential expression of sphingolipids in MRP1 overexpressing HT29 cells. Int. J. Cancer. 87: 172-178.
8. Sietsma, H., R. J. Veldman, D. Kolk, B. Ausema, W. Nijhof, W. Kamps, E. Vellenga, and J. W. Kok. 2000. 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin. Cancer Res. 6: 942-948.
9. Olshefski, R. S., and S. Ladisch. 2001. Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity. Int. J. Cancer. 93: 131-138.
10. Di Bartolomeo, S., and A. Spinedi. 2001. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells. Biochem. Biophys. Res. Commun. 288: 269-274.
11. Kaucic, K., N. Etue, B. LaFleur, W. Woods, and S. Ladisch. 2001. Neuroblastomas of infancy exhibit a characteristic ganglioside pattern. Cancer. 91: 785-793.
12. Kushner, B. H., K. Kramer, and N. K. Cheung. 2001. Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. J. Clin. Oncol. 19: 4189-4194.
13. Pagnan, G., D. D. Stuart, F. Pastorino, L. Raffaghello, P. G. Montaldo, T. M. Allen, B. Calabretta, and M. Ponzoni. 2000. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. J. Natl. Cancer Inst. 92: 253-261.
14. Li, R., N. Villacreses, and S. Ladisch. 1995. Human tumor gangliosides inhibit murine immune responses in vivo. Cancer Res. 55: 211-214.
15. Floutsis, G., L. Ulsh, and S. Ladisch. 1989. Immunosuppressive activity of human neuroblastoma tumor gangliosides. Int. J. Cancer. 43: 6-9.
16. Sietsma, H., W. Nijhof, B. Dontje, E. Vellenga, W. A. Kamps, and J. W. Kok. 1998. Inhibition of hemopoiesis in vitro by neuroblastoma-derived gangliosides. Cancer Res. 58: 4840-4844.
17. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31-39.
18. Brown, D. A., and E. London. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221-17224.
19. Prinetti, A., K. Iwabuchi, and S. Hakomori. 1999. Glycosphingolipid- enriched signaling domain in mouse neuroblastoma Neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J. Biol. Chem. 274: 20916-20924.
20. Lavie, Y., G. Fiucci, and M. Liscovitch. 1998. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273: 32380-32383.
21. Demeule, M., J. Jodoin, D. Gingras, and R. Beliveau. 2000. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett. 466: 219-224.
22. Hinrichs, J. W. J., K. Klappe, I. Hummel, and J. W. Kok. 2004. ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells. J. Biol. Chem. 279: 5734-5738.
23. Plo, I., G. Lehne, K. J. Beckström, N. Maestre, A. Bettaïeb, G. Laurent, and D. Lautier. 2002. Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells. Mol. Pharmacol. 62: 304-312.
24. Dijkhuis, A. J., J. Douwes, W. Kamps, H. Sietsma, and J. W. Kok. 2003. Differential expression of sphingolipids in P-glycoprotein or multidrug resistance-related protein 1 expressing human neuroblastoma cell lines. FEBS Lett. 548: 28-32.
25. Senn, H. J., M. Orth, E. Fitzke, H. Wieland, and W. Gerok. 1998. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur. J. Biochem. 181: 657-662.
26. Ladisch, S., and B. Gillard. 1985. A solvent partition method for microscale ganglioside purification. Anal. Biochem. 146: 220-231.
27. Böttcher, C. J. F., C. M. van Gent, and C. Pries. 1961. A rapid and sensitive submicro phosphorus determination. Anal. Chim. Acta. 24: 203-204.
28. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Chem. 150: 76-85.
29. Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-942.
30. Lisanti, M. P., Z. Tang, P. E. Scherer, and M. Sargiacomo. 1995. Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol. 250: 655-668.
31. Smith, A. J., J. L. Timmermans-Hereijgers, B. Roelofsen, K. W. Wirtz, W. J. van Blitterswijk, J. J. Smit, A. H. Schinkel, and P. Borst. 1994. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354: 263-266.
32. Raggers, R. J., A. van Helvoort, R. Evers, and G. van Meer. 1999. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell Sci. 112: 415-422.
33. Eckford, P. D. W., and F. J. Sharom. 2005. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. Biochem. J. 389: 517-526.
34. Prinetti, A., L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al. 2003. Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells. J. Biol. Chem. 278: 5574-5583.
35. Hummel, I., K. Klappe, and J. W. Kok. 2005. Up-regulation of lactosylceramide synthase in MDR1 overexpressing human liver tumour cells. FEBS Lett. 579: 3381-3384.
36. Sietsma, H., A. J. Dijkhuis, W. Kamps, and J. W. Kok. 2002. Sphingolipids in neuroblastoma: their role in drug resistance mechanisms. Neurochem. Res. 27: 665-674.
37. Norris-Cervetto, E., R. Callaghan, F. M. Platt, R. A. Dwek, and T. D. Butters. 2004. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells. J. Biol. Chem. 279: 40412-40418.
38. Klappe, K., J. W. J. Hinrichs, B. J. Kroesen, H. Sietsma, and J. W. Kok. 2004. MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells. Int. J. Cancer. 110: 511-522.
39. Kok, J. W., and H. Sietsma. 2004. Sphingolipid metabolism enzymes as targets for anti-cancer therapy. Curr. Drug Targets. 5: 375-382.
40. Dijkhuis, A. J., K. Klappe, S. Jacobs, B. J. Kroesen, W. Kamps, H. Sietsma, and J. W. Kok. 2006. PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol. Cancer Ther. 5: 593-601.